Skip to main content

Primary Nutritional Issues with Parkinson's Disease

Parkinson's disease is a progressive, disabling, neurodegenerative disease affecting approximately 1% to 2% of the population that is over 60 years of age.

Back to News Center
Parkinson's disease is a progressive, disabling, neurodegenerative disease resulting from a decreased production of dopamine by the substantia nigra cells in the basal ganglia of the brain. It affects approximately 1% to 2% of the population that is over 60 years of age. The main treatments for managing this disease are prescription drugs, such as levodopa and monoamine oxidase inhibitors (MAOIs), surgical interventions and physical and occupational therapy.

Join the Academy

Members of the Academy of Nutrition and Dietetics receive exciting benefits including complimentary continuing professional education opportunities, discounts on events and products in eatrightSTORE.org, invitations to exclusive members-only events and more!

Log in or join

Please log in to access this page.

This content is an exclusive benefit for Academy members. If you are a member of the Academy, log in for immediate access! Not yet a member? Unlock benefits, tools, resources and discounts by joining today.

Member Login Member Benefits